| Dr Joseph H Brewer, MD | |
|
4320 Wornall Rd, Suite 440, Kansas City, MO 64111-5941 | |
| (816) 531-1550 | |
| Not Available |
| Full Name | Dr Joseph H Brewer |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 44 Years |
| Location | 4320 Wornall Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417981846 | NPI | - | NPPES |
| 100203000A | Medicaid | KS | |
| 202229217 | Medicaid | MO | |
| 8583019 | Other | MO | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | R7911 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medicines Agency (EMA) has adopted a positive opinion and recommends the granting of orphan medicinal product designation for XOMA 052, an antibody to interleukin-1 beta, for the treatment of Behcet's disease. Positive opinions are submitted to the European Commission for decision and are generally adopted within 30 days of receipt.
ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced its acquisition of Rocol SA, a leader in the commercialization of medical equipment across Latin America. Terms of the acquisition were not disclosed.
People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a "stent" surgical tube, the artery is much more likely to clog up again.
› Verified 9 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medicines Agency (EMA) has adopted a positive opinion and recommends the granting of orphan medicinal product designation for XOMA 052, an antibody to interleukin-1 beta, for the treatment of Behcet's disease. Positive opinions are submitted to the European Commission for decision and are generally adopted within 30 days of receipt.
ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced its acquisition of Rocol SA, a leader in the commercialization of medical equipment across Latin America. Terms of the acquisition were not disclosed.
People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a "stent" surgical tube, the artery is much more likely to clog up again.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph H Brewer, MD 4320 Wornall Road, Suite 440, Kansas City, MO 66211-1335 Ph: (816) 531-1550 | Dr Joseph H Brewer, MD 4320 Wornall Rd, Suite 440, Kansas City, MO 64111-5941 Ph: (816) 531-1550 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the Committee for Orphan Medical Products of the European Medicines Agency (EMA) has adopted a positive opinion and recommends the granting of orphan medicinal product designation for XOMA 052, an antibody to interleukin-1 beta, for the treatment of Behcet's disease. Positive opinions are submitted to the European Commission for decision and are generally adopted within 30 days of receipt.
ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced its acquisition of Rocol SA, a leader in the commercialization of medical equipment across Latin America. Terms of the acquisition were not disclosed.
People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a "stent" surgical tube, the artery is much more likely to clog up again.
› Verified 9 days ago
Maria Akram Sheikh, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Dr. Philip Barigbi Augustine, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4150 N Mulberry Dr, Kansas City, MO 64116 Phone: 816-912-4539 Fax: 855-813-6642 | |
Lucas Vocelka, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd, Bldg 2, Suite 392, Kansas City, MO 64132 Phone: 816-444-7977 Fax: 630-528-9578 | |
Karla L Houston-gray, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr Ste 300, Kansas City, MO 64114 Phone: 816-942-4500 Fax: 816-941-4504 | |
Carl D Dirks, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4320 Wornall Rd, Suite 65, Kansas City, MO 64111 Phone: 816-932-6100 Fax: 816-932-9002 | |
Michelle L Dew, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4330 Wornall Rd, Suite 2000, Kansas City, MO 64111 Phone: 816-931-1883 Fax: 816-756-3645 | |
Brenda J Rogers, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |